Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 7.9B | 8.5B | 7.7B | 7.2B |
Cost of revenue | 5.6B | 5.9B | 5.3B | 4.8B |
Gross profit | 2.3B | 2.6B | 2.4B | 2.4B |
Operating expense | ||||
Research & development | 475M | 527M | 547M | 590M |
Selling general and admin | 1.3B | 1.2B | 1.2B | 1.2B |
Other operating expenses | — | — | — | — |
Operating income | 514M | 799M | 603M | 504M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | 22M |
Other income expense | 180M | 613M | 17M | -37M |
Pretax income | 733M | 1.4B | 608M | 445M |
Tax provision | 106M | 51M | 96M | 131M |
Net income | 627M | 1.4B | 512M | 314M |
Basic EPS | 0.5 | 1.0 | 0.4 | 0.2 |
Diluted EPS | 0.4 | 1.0 | 0.4 | 0.2 |
Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
Diluted average shares | 1.4B | 1.4B | 1.3B | 1.3B |
EBITDA | 950M | 812M | 1.3B | 1.2B |
Net income from continuing op. | 627M | 1.4B | 512M | 314M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |